Skip to content

Impact of Patient's Therapeutic Education in APA and Dietetic on Radiotherapy Reproducibility Sessions for Prostate Cancer

ETADAPT- Evaluation of the Impact of Patient's Therapeutic Education (PTE) in Adapted Physical Activity (APA) and Dietetic on the Reproducibility of Radiotherapy Sessions for Prostate Cancers.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04832113
Acronym
ETADAPT
Enrollment
216
Registered
2021-04-05
Start date
2021-06-21
Completion date
2025-04-30
Last updated
2023-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

The primary objective of this study is to evaluate the impact of Patient's Therapeutic Education (PTE) in Adapted Physical Activity (APA) ans dietetic on the reduction of interventions number on rectal volume (laxative or probe). The secondary objectives are to evaluate the contribution of Patient's Therapeutic Education (PTE) between the 2 arms on repositionnind during the radiotherapy session, the gastrointestinal toxicity, the need to use laxative or transit regulating treatment or techniques, the quality of life, the undernutrition and food intake, the evolution in eating/hydratation and physical habits. For the experimetal arm, the satisfaction and the compliance with PTE program will be evaluated, as well as the need of additionnal use of dietary and APA consultations.

Detailed description

Prostate cancer is the 3rd cause of cancer mortality in patient aged over 50 years. Radiotherapy treatment plans require specific conditions: * Reproductibility of patient's positioning (requiring management of bladder and rectal fillings at each session). * An image-guided treatment consisting in acquiring an image before each session. This pre-treatment Imaging allows the optimal adjustment of the target volume and organs at risk (bladder and rectum). To allow reproductibility of target volume positioning at each radiotherapy session, it's recommended to have an empty rectum at the time of the radiotherapy preparation scan, and to check repletion before each session. It's recommended that the patient has a comfortably full bladder to limit the volume of irradiated bladder mucosa. The radiotherapy teams don't have any recommendations concerning the rectum and manage this problem session by session, according to the repositioning Imaging of the current day. According to a pilot study carried out in 2017 in the radiotherapy department of the Léon Bérard center, an intervention for a dilated rectum (probe or laxative) was necessary for an average of 25% of session per patient. These rectal problems can be partly explained by the age (60-80 years) and sedentary lifestyle of patients with prostate cancer. Physical activities, adapted hydratation and changes in eating habits are an integral part of the constipation and flatulence prevention.

Interventions

OTHERAdapted Physical Activity and Dietetic

session in addtion conventional management dietetic, hydratation and physical activity

Dietary and hydratation advices according to the recommendations

Sponsors

Centre Leon Berard
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

I1: Age \>= 18 years old. I2: Patient with prostatic adenocarcinoma with indication for first-line or post-operative radiotherapy (adjuvant or biologic recurrence). I3: Patient able to practice a physical activity (certificate of aptitude for adapted physical activity). I4: Life expectancy greater than 6 months. I5: Absence of chronic inflammatory intestinal disease or intestinal surgery. I6: Signed informed consent. I7: Patient covered by a medical insurance. I8. At least 20 sessions of radiotherapy planned

Exclusion criteria

E1: Patient does not understand and cannot read French. E2: Patient followed for a psychiatric pathology or presenting cognitive disorders. E3: Inability to comply with study follow-up goegraphical, social or psychological reasons. E4: Patient requiring tutorship or curatorship or patient deprived of liberty. E5: Participation to another clinical trial which may interfere with principal Endpoint assessment.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the impact of Patient's Therapeutic Education in APA on the reduction of interventions number on rectumAn average of 4 monthsNumber of uninstallation during the radiotherapy session

Secondary

MeasureTime frameDescription
Evaluate the contribution of Patient's Therapeutic Education on the evolution in eating habitsAn average of 4 monthsUsing the Eating and hydration habits questionnaire
Evaluate the contribution of Patient's Therapeutic Education on patient's repositionning efficiencyAn average of 4 monthsRate of patients never uninstalled compared to patients uninstalled during prostate's radiotherapy
Evaluate the contribution of Patient's Therapeutic Education on the gastrointestinal toxicityAn average of 4 monthsAcute gastrointestinal toxicity ≥ grade 2 (NCI- CTCAE V5)
Evaluate the contribution of Patient's Therapeutic Education on the use of laxative or transit regulating treatment or techniquesAn average of 4 monthsPrescribed laxatives or transit regulation treatments or techniques
Evaluate the contribution of Patient's Therapeutic Education on patients' quality of lifeAn average of 4 monthsUsing European Organisation for Research and Treatment of Cancer - Core Quality of life questionnaire (QLQC30) (Evaluation of patient's quality of life during the last 7 days - From 4 \[worse reply\] to 1 \[better reply\])
Evaluate the contribution of Patient's Therapeutic Education on the undernutritionAn average of 4 monthsCollection of patients' weight (kg)
Evaluate the contribution of Patient's Therapeutic Education on the food intakeAn average of 4 monthsCollection of patients' weight (kg)
Evaluate the contribution of Patient's Therapeutic Education on the evolution in APA habitsAn average of 4 monthsUsing International Physical Activity Questionnaire (IPAQ) (Description of the physical activity during the last 7 days)
Evaluate patient's satisfaction with Patient's Therapeutic Education program (experimental arm)An average of 4 monthsUsing satisfaction questionnaire (scale from 1 \[worse evaluation\] to 4 \[better evaluation\])
Evaluate the compliance to APA session recommendationsAn average of 4 monthsDaily collection of steps numbers
Evaluate the number of patients requiring additional dietetic sessionAn average of 4 monthsEvaluation during phone calls every 15 days
Evaluate the number of patients requiring additional APA sessionAn average of 4 monthsEvaluation during phone calls every 15 days
Evaluate the contribution of Patient's Therapeutic Education on the evolution in hydratation habitsAn average of 4 monthsUsing the Eating and hydration habits questionnaire

Countries

France

Contacts

Primary ContactSéverine METZGER
severine.metzger@lyon.unicancer.fr+33478782786
Backup ContactPascale Roux
pascale.roux@lyon.unicancer.fr+33478787200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026